Long-sleeved clothing and permethrin-treated garments during outdoor activities in endemic areas
Avoidance of outdoor activity at dawn and dusk when Culiseta and bridge vectors are most active
Mosquito source reduction: elimination of standing water near residences
Community mosquito surveillance and aerial spraying programmes in outbreak settings
No human vaccine available; ongoing research into alphavirus vaccines
Patient Discharge Instructions
copy discharge instructions
Discharge instructions for Eastern Equine Encephalitis
You were treated for Eastern Equine Encephalitis (EEE), a rare but serious brain infection spread by mosquito bites
There is no specific antiviral medication; your treatment focused on supportive care and preventing complications
Recovery can take weeks to months; many survivors experience lasting neurologic effects
Medications at discharge
Take all prescribed anti-seizure medications exactly as directed; do not stop without your neurologist's approval
Take all other prescribed medications as directed
Activity and diet
No driving until cleared by your neurologist, particularly if you had seizures
Follow a soft or modified diet if you have swallowing difficulty
Attend all scheduled rehabilitation appointments (physical, occupational, speech therapy)
Prevention after discharge
Use EPA-registered insect repellent (DEET, picaridin, or IR3535) on all exposed skin when outdoors
Wear long-sleeved shirts and long pants when outdoors in wooded or wetland areas
Avoid outdoor activities at dawn and dusk when mosquitoes are most active
Eliminate standing water around your home (birdbaths, flowerpots, gutters)
Return to the emergency department immediately if you experience
New seizure or worsening seizure activity
Sudden decline in mental status or increasing confusion
New weakness, numbness, or difficulty speaking
Fever greater than 38.3 degrees Celsius returning after discharge
Inability to keep medications down due to vomiting
Any sudden or severe headache
References
Guidelines and key sources
Primary references
Staples JE, Gould CV. Eastern Equine Encephalitis in the US. JAMA. 2025. doi:10.1001/jama.2025.9073
Comprehensive review of 193 CDC-reported cases 2005–2024
Epidemiology, clinical features, management, and outcomes
Garcia-Dominguez MA, Moonis M, Kipkorir V, Srichawla BS. The Clinical and Radiographic Features of Eastern Equine Encephalitis: A Single-Center Retrospective Case Series. Medicine. 2024. PMID: 39969305
Detailed MRI and CT imaging characterisation
Prognostic correlates of neuroimaging abnormalities
Wilcox DR, Collens SI, Solomon IH, Mateen FJ, Mukerji SS. Eastern Equine Encephalitis and Use of IV Immunoglobulin Therapy and High-Dose Steroids. Neurology Neuroimmunol Neuroinflammation. 2021. PMID: 33172962
N=17 retrospective series evaluating IVIG and steroid use
Earlier IVIG associated with reduced long-term disability
Ruiz C, Gibson G, Rojas S, Friend K. Eastern Equine Encephalitis Virus: A Case Report and Brief Literature Review. Vector Borne Zoonotic Dis. 2024. PMID: 37870590
Case report with literature review of therapeutic strategies
Ladzinski AT et al. Clinical Characteristics of the 2019 Eastern Equine Encephalitis Outbreak in Michigan. Open Forum Infect Dis. 2023. PMID: 37180595
Outbreak series with clinical characteristics and diagnostic delays
Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and Neuroradiographic Manifestations of Eastern Equine Encephalitis. N Engl J Med. 1997;336:1867–1874
Landmark NEJM series defining MRI and CT patterns in EEE
Mermel LA. Association of Human Eastern Equine Encephalitis With Precipitation Levels in Massachusetts. JAMA Netw Open. 2020. doi:10.1001/jamanetworkopen.2019.20261
Epidemiologic study linking precipitation to EEE case frequency
Strelau KM et al. Notes From the Field: Increase in Eastern Equine Encephalitis Virus Activity - Vermont, 2023–2024. MMWR. 2026. PMID: 42060520
Emerging geographic expansion into northern New England
Lindsey NP, Staples JE, Fischer M. Eastern Equine Encephalitis Virus in the United States, 2003–2016. Am J Trop Med Hyg. 2018. PMID: 29557336
National surveillance data and epidemiologic trends
Foundational review of viral encephalitis differential diagnosis and management
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.